OPK

Opko Health

• Benzinga·07/02 21:05

  12 Health Care Stocks Moving In Thursday's After-Market Session

• Simply Wall St·07/02 19:33

  OPKO Health (OPK) Ownership Update Draws Attention, Is The 55% Undervalued View Convincing?

• Simply Wall St·06/24 00:36

  OPKO Health (OPK) Stock Could Be 57% Undervalued As Margin Recovery Comes Into Focus

• TipRanks·06/18 20:57

  Opko Health Shareholders Back Board, Equity and Auditors

• PUBT·06/18 20:07

  Opko Health shareholders approve 2026 equity incentive plan at annual meeting

• Simply Wall St·06/16 18:33

  OPKO Health (OPK) Stock Could Be 58.8% Undervalued After OPK8801001 Preclinical Update

• TipRanks·06/16 13:36

  Entera Bio and Opko Health present preclinical data for oral peptides

• Benzinga·06/16 12:44

  Entera Bio Reports Preclinical Results For Oral Peptide Programs EB612 And EB618, Advancing Toward Clinical Development

• PUBT·06/15 12:01

  Opko Health presents preclinical data for weekly acromegaly drug candidate OPK8801001 at ENDO 2026

• TipRanks·06/15 11:03

  Piper Sandler Sticks to Their Buy Rating for Opko Health (OPK)

• Simply Wall St·06/11 15:18

  Should OPKO’s New 15% Nicoya Stake and RAYALDEE Terms Require Action From OPKO Health (OPK) Investors?

• Simply Wall St·06/08 16:21

  A Look At OPKO Health’s Valuation As Nicoya Agreement Expands RAYALDEE Opportunity In Asian Renal Care

• Simply Wall St·06/06 02:27

  OPKO Deepens Nicoya Alliance As RAYALDEE China Prospects Draw Focus

• TipRanks·06/04 15:16

  Private Markets: Anthropic files confidentially for IPO with SEC

• TipRanks·05/26 17:47

  H.C. Wainwright Sticks to Their Buy Rating for Opko Health (OPK)